294 related articles for article (PubMed ID: 17853944)
1. Redox modifier genes in amyotrophic lateral sclerosis in mice.
Marden JJ; Harraz MM; Williams AJ; Nelson K; Luo M; Paulson H; Engelhardt JF
J Clin Invest; 2007 Oct; 117(10):2913-9. PubMed ID: 17853944
[TBL] [Abstract][Full Text] [Related]
2. Alsin and SOD1(G93A) proteins regulate endosomal reactive oxygen species production by glial cells and proinflammatory pathways responsible for neurotoxicity.
Li Q; Spencer NY; Pantazis NJ; Engelhardt JF
J Biol Chem; 2011 Nov; 286(46):40151-62. PubMed ID: 21937428
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of NADPH oxidases as drug targets in a mouse model of familial amyotrophic lateral sclerosis.
Seredenina T; Nayernia Z; Sorce S; Maghzal GJ; Filippova A; Ling SC; Basset O; Plastre O; Daali Y; Rushing EJ; Giordana MT; Cleveland DW; Aguzzi A; Stocker R; Krause KH; Jaquet V
Free Radic Biol Med; 2016 Aug; 97():95-108. PubMed ID: 27212019
[TBL] [Abstract][Full Text] [Related]
4. SOD1 mutations disrupt redox-sensitive Rac regulation of NADPH oxidase in a familial ALS model.
Harraz MM; Marden JJ; Zhou W; Zhang Y; Williams A; Sharov VS; Nelson K; Luo M; Paulson H; Schöneich C; Engelhardt JF
J Clin Invest; 2008 Feb; 118(2):659-70. PubMed ID: 18219391
[TBL] [Abstract][Full Text] [Related]
5. ALS predisposition modifiers: knock NOX, who's there? SOD1 mice still are.
Valdmanis PN; Kabashi E; Dion PA; Rouleau GA
Eur J Hum Genet; 2008 Feb; 16(2):140-2. PubMed ID: 18043718
[No Abstract] [Full Text] [Related]
6. The NADPH oxidase pathway is dysregulated by the P2X7 receptor in the SOD1-G93A microglia model of amyotrophic lateral sclerosis.
Apolloni S; Parisi C; Pesaresi MG; Rossi S; Carrì MT; Cozzolino M; Volonté C; D'Ambrosi N
J Immunol; 2013 May; 190(10):5187-95. PubMed ID: 23589615
[TBL] [Abstract][Full Text] [Related]
7. Redox modifier genes and pathways in amyotrophic lateral sclerosis.
Carter BJ; Anklesaria P; Choi S; Engelhardt JF
Antioxid Redox Signal; 2009 Jul; 11(7):1569-86. PubMed ID: 19187001
[TBL] [Abstract][Full Text] [Related]
8. NADPH oxidase (NOX2) activity is a modifier of survival in ALS.
Marrali G; Casale F; Salamone P; Fuda G; Caorsi C; Amoroso A; Brunetti M; Restagno G; Barberis M; Bertuzzo D; Canosa A; Moglia C; Calvo A; Chiò A
J Neurol; 2014 Nov; 261(11):2178-83. PubMed ID: 25178511
[TBL] [Abstract][Full Text] [Related]
9. Ablation of P2X7 receptor exacerbates gliosis and motoneuron death in the SOD1-G93A mouse model of amyotrophic lateral sclerosis.
Apolloni S; Amadio S; Montilli C; Volonté C; D'Ambrosi N
Hum Mol Genet; 2013 Oct; 22(20):4102-16. PubMed ID: 23736299
[TBL] [Abstract][Full Text] [Related]
10. Revisiting oxidative damage in ALS: microglia, Nox, and mutant SOD1.
Boillée S; Cleveland DW
J Clin Invest; 2008 Feb; 118(2):474-8. PubMed ID: 18219386
[TBL] [Abstract][Full Text] [Related]
11. In-vivo genetic ablation of metabotropic glutamate receptor type 5 slows down disease progression in the SOD1
Bonifacino T; Provenzano F; Gallia E; Ravera S; Torazza C; Bossi S; Ferrando S; Puliti A; Van Den Bosch L; Bonanno G; Milanese M
Neurobiol Dis; 2019 Sep; 129():79-92. PubMed ID: 31102766
[TBL] [Abstract][Full Text] [Related]
12. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.
Jaarsma D; Haasdijk ED; Grashorn JA; Hawkins R; van Duijn W; Verspaget HW; London J; Holstege JC
Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261
[TBL] [Abstract][Full Text] [Related]
13. Nox1 upregulates the function of vascular T-type calcium channels following chronic nitric oxide deficit.
Howitt L; Matthaei KI; Drummond GR; Hill CE
Pflugers Arch; 2015 Apr; 467(4):727-35. PubMed ID: 24923576
[TBL] [Abstract][Full Text] [Related]
14. Stabilization of mutant Cu/Zn superoxide dismutase (SOD1) protein by coexpressed wild SOD1 protein accelerates the disease progression in familial amyotrophic lateral sclerosis mice.
Fukada K; Nagano S; Satoh M; Tohyama C; Nakanishi T; Shimizu A; Yanagihara T; Sakoda S
Eur J Neurosci; 2001 Dec; 14(12):2032-6. PubMed ID: 11860498
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-6 Deficiency Does Not Affect Motor Neuron Disease Caused by Superoxide Dismutase 1 Mutation.
Han Y; Ripley B; Serada S; Naka T; Fujimoto M
PLoS One; 2016; 11(4):e0153399. PubMed ID: 27070121
[TBL] [Abstract][Full Text] [Related]
16. Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortex.
Thomsen GM; Gowing G; Latter J; Chen M; Vit JP; Staggenborg K; Avalos P; Alkaslasi M; Ferraiuolo L; Likhite S; Kaspar BK; Svendsen CN
J Neurosci; 2014 Nov; 34(47):15587-600. PubMed ID: 25411487
[TBL] [Abstract][Full Text] [Related]
17. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
[TBL] [Abstract][Full Text] [Related]
18. "Preconditioning" with latrepirdine, an adenosine 5'-monophosphate-activated protein kinase activator, delays amyotrophic lateral sclerosis progression in SOD1(G93A) mice.
Coughlan KS; Mitchem MR; Hogg MC; Prehn JH
Neurobiol Aging; 2015 Feb; 36(2):1140-50. PubMed ID: 25443289
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of Abeta is associated with acceleration of onset of motor impairment and superoxide dismutase 1 aggregation in an amyotrophic lateral sclerosis mouse model.
Li QX; Mok SS; Laughton KM; McLean CA; Volitakis I; Cherny RA; Cheung NS; White AR; Masters CL
Aging Cell; 2006 Apr; 5(2):153-65. PubMed ID: 16626394
[TBL] [Abstract][Full Text] [Related]
20. Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets.
Drummond GR; Selemidis S; Griendling KK; Sobey CG
Nat Rev Drug Discov; 2011 Jun; 10(6):453-71. PubMed ID: 21629295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
